These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15934914)

  • 21. Control and prevention of MRSA infections.
    Wang L; Barrett JF
    Methods Mol Biol; 2007; 391():209-25. PubMed ID: 18025680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
    Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
    Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community-associated methicillin-resistant Staphylococcus aureus: a review.
    Rybak MJ; LaPlante KL
    Pharmacotherapy; 2005 Jan; 25(1):74-85. PubMed ID: 15767223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS).
    Gastmeier P; Sohr D; Geffers C; Behnke M; Daschner F; Rüden H
    Infection; 2005 Apr; 33(2):50-5. PubMed ID: 15827870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sitafloxacin in the treatment of patients with infections caused by vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus.
    Shetty N; Wilson AP
    J Antimicrob Chemother; 2000 Oct; 46(4):633-8. PubMed ID: 11020265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections.
    Seybold U; Kourbatova EV; Johnson JG; Halvosa SJ; Wang YF; King MD; Ray SM; Blumberg HM
    Clin Infect Dis; 2006 Mar; 42(5):647-56. PubMed ID: 16447110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of methicillin-resistant Staphylococcus aureus isolated from dogs in Korea.
    Pak SI; Han HR; Shimizu A
    J Vet Med Sci; 1999 Sep; 61(9):1013-8. PubMed ID: 10535519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: clinical significance of non-multi-resistant antibiogram and Panton-Valentine leukocidin gene.
    Wang JL; Wang JT; Chen SY; Hsueh PR; Kung HC; Chen YC; Chang SC
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):365-71. PubMed ID: 17878063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study on the resistance of methicillin resistant Staphylococcus aureus to antimicrobial agents].
    Wang R; Nishioka K; Tanno Y
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):95-8. PubMed ID: 8070299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF; Frank AL
    Curr Opin Infect Dis; 2003 Jun; 16(3):265-9. PubMed ID: 12821819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan.
    Chen CJ; Huang YC
    J Microbiol Immunol Infect; 2005 Dec; 38(6):376-82. PubMed ID: 16341337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the resistance of methicillin-resistant staphylococcus aureus to iodophor and chlorhexidine].
    Zhang YH; Liu XY; Zhu LL; Yu YZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):248-50. PubMed ID: 15200941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California.
    Huang H; Flynn NM; King JH; Monchaud C; Morita M; Cohen SH
    J Clin Microbiol; 2006 Jul; 44(7):2423-7. PubMed ID: 16825359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CA-MRSA shown to be an emerging problem.
    ED Manag; 2008 Jul; 20(7):79-81. PubMed ID: 18686896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
    Neela V; Sasikumar M; Ghaznavi GR; Zamberi S; Mariana S
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):885-92. PubMed ID: 19058585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit.
    Haddadin AS; Fappiano SA; Lipsett PA
    Postgrad Med J; 2002 Jul; 78(921):385-92. PubMed ID: 12151652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing therapy for MRSA pneumonia.
    Skrupky LP; Micek ST; Kollef MH
    Semin Respir Crit Care Med; 2007 Dec; 28(6):615-23. PubMed ID: 18095225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciprofloxacin resistanceamong community-derived methicillin-resistant Staphylococcus aureus (MRSA) strains.
    Lqbal J; Rahman M; Kabir MS
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):779-80. PubMed ID: 10928376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.